GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO, S.L.;MONASH UNIVERSITY;UNIVERSITY OF WASHINGTON;BOARD OF REGENTS;BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM; THE UNIVERSITY OF TEXAS SYSTEM;MMV MEDICINES FOR MALARIA VENTURE
发明人:
RATHOD PRADIPSINH K.,FLOYD DAVID,BURROWS JEREMY,MARWAHA ALKA,GUJJAR RAMESH,COTERON-LOPEZ JOSE,PHILLIPS MARGARET,CHARMAN SUSAN A.,MATTHEWS DAVID,RATHOD Pradipsinh K.,FLOYD David,BURROWS Jeremy,MARWAHA Alka,GUJJAR Ramesh,COTERON-LOPEZ Jose,PHILLIPS MAR
申请号：
SI201030853
公开号：
SI2483274T1
申请日:
2010.09.28
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
Inhibitors of parasitic dihydroorotate dehydrogenase enzyme (DHOD) are candidate therapeutics for treating malaria. Illustrative of such therapeutic agents include the compound: and a triazolopyrimidine class of compounds that conform to Formula IX: and their solvates, stereoisomers, tautomers and pharmaceutically acceptable salts.
